Key facts
- It has raised $200.0M across 1 recorded rounds; the latest was PIPE ($200.0M) in Feb 2024.
- 5 institutional filers report fund marks on Tyra Biosciences across 16 filings.
- Tyra Biosciences has filed 1 Form D with the SEC, most recently Feb 2024 ($200.0M sold to 21 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Tyra Biosciences
Create free account
No card required
Funding rounds
1 roundsFeb 2024PIPE$200.0M▮
About Tyra Biosciences
- Industry
- Drug Discovery
PA Mark — not yet priced
Tyra Biosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Tyra Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
5 filers · latest Jun 20265 SEC-registered funds reported 16 fair-value marks on Tyra Biosciences between Apr 2025 and Jun 2026. Filer-level marks and implied $/share are available to Pro members.